Nina Nelson
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Personalized chronotherapy in glioblastoma: integrating circadian profiling and PK-PD modelling to optimize temozolomide timing.
Journal: NPJ precision oncology
Published: July 31, 2025
Circadian rhythm disruption by PARP inhibitors correlates with treatment toxicity in patients with ovarian cancer and is a predictor of side effects.
Journal: EBioMedicine
Published: November 20, 2024
Comprehensive integrative analysis of circadian rhythms in human saliva.
Journal: Npj biological timing and sleep
Published: April 28, 2024
Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock.
Journal: NPJ precision oncology
Published: July 12, 2023
Reduced expression and activity of patient-derived SHIP1 phosphatase domain mutants.
Journal: Cellular signalling
Published: March 23, 2022
AKT1 and PTEN show the highest affinities among phosphoinositide binding proteins for the second messengers PtdIns(3,4,5)P3 and PtdIns(3,4)P2.
Journal: Biochemical and biophysical research communications
Published: June 02, 2021
Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia.
Journal: Nature communications
Published: February 03, 2021
Ectopic Expression of Hematopoietic SHIP1 in Human Colorectal Cancer.
Journal: Biomedicines
Published: May 19, 2020
Characterization of the substrate specificity of the inositol 5-phosphatase SHIP1.
Journal: Biochemical and biophysical research communications
Published: December 07, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026